Related references
Note: Only part of the references are listed.Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01)
Satoru Iwase et al.
SUPPORTIVE CARE IN CANCER (2016)
The Adjuvant Nutritional Intervention in Cancer (ANICA) Trial
Geir Bjorklund
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2015)
Lack of Effect of Coenzyme Q10 on Doxorubicin Cytotoxicity in Breast Cancer Cell Cultures
Heather Greenlee et al.
INTEGRATIVE CANCER THERAPIES (2012)
Low Plasma Coenzyme Q10 Levels and Breast Cancer Risk in Chinese Women
Robert V. Cooney et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Plasma Coenzyme Q10 Levels and Postmenopausal Breast Cancer Risk: The Multiethnic Cohort Study
Weiwen Chai et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model
Massih Bahar et al.
NUTRITION JOURNAL (2010)
Effect of Coenzyme Q10, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles
Srinivasan Yuvaraj et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Antiangiogenic and hypolipidemic activity of coenzyme Q(10) supplementation to breast cancer patients undergoing Tamoxifen therapy
Panchanatham Sachdanandam
BIOFACTORS (2008)
Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy
Vummidi Giridhar Premkumar et al.
BRITISH JOURNAL OF NUTRITION (2008)
Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy
Vummidi Giridhar Premkumar et al.
VASCULAR PHARMACOLOGY (2008)
Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin
Srinivasan Yuvaraj et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Serum cytokine levels of interleukin-1β, -6, -8, tumour necrosis factor-α and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q10, riboflavin and niacin
Vummidi Giridhar Premkumar et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy
Vummidi Giridhar Premkumar et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Ameliorating effect of coenzyme Q(10), riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins
Srinivasan Yuvaraj et al.
CLINICAL BIOCHEMISTRY (2007)
Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10:: Effects on lipid peroxidation and antioxidants in mitochondria
SS Perumal et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2005)
Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients
O Portakal et al.
CLINICAL BIOCHEMISTRY (2000)
Share Paper
